Palliative Care: Non-Pharmacological and Pharmacological Management Strategies
The most effective palliative care approach combines targeted non-pharmacological interventions with appropriate pharmacological management, tailored to the patient's estimated life expectancy and specific symptoms. 1
Assessment and General Approach
Based on Life Expectancy
- Years to live: Focus on disease-modifying treatments alongside symptom management
- Months to weeks: Transition to primarily symptom-focused care, consider discontinuing disease-modifying treatments
- Weeks to days: Intensify palliative interventions, discontinue non-essential medications, focus exclusively on comfort 1
Non-Pharmacological Management Strategies
Physical Symptom Management
Dyspnea management:
Pain management:
- Acupuncture
- Physical therapy
- Mindfulness-based stress reduction
- Music therapy 1
Edema/Fluid management:
- Support stockings/leg elevation
- Long-term in-dwelling drains for chronic pleural effusions and ascites 1
Environmental Interventions
- Create a safe, aesthetic, and pleasing environment 2
- Reduce excessive stimuli (noise, light)
- Ensure comfortable room temperature
- Provide familiar objects for comfort and orientation 1
Psychosocial and Spiritual Support
- Emotional support for patients and caregivers
- Educational interventions about disease progression and expected symptoms
- Spiritual care aligned with patient's beliefs
- Counseling for anticipatory grief 1
- Cognitive behavioral therapy for anxiety and depression 3
Communication and Advance Care Planning
- Discuss goals of care and treatment preferences early
- Complete advance directives and ensure availability across all care settings 1
- Determine preferred place of death 1
- Address family conflicts regarding goals of care 4
Pharmacological Management by Symptom
Dyspnea
- First-line: Morphine 2.5-10 mg PO q2h PRN or 1-3 mg IV q2h PRN 1
- For anxiety-associated dyspnea: Add benzodiazepines (lorazepam 0.5-1 mg PO q4h PRN) 1
- For excessive secretions: Scopolamine 0.4 mg subcutaneous q4h PRN or 1.5 mg patches 4
- Note: Oxygen therapy only beneficial for symptomatic hypoxia 1
Pain
- Mild pain: Acetaminophen/paracetamol 4
- Moderate-severe pain: Opioids (morphine as first-line) 1, 4
- Neuropathic pain: Add anticonvulsants or antidepressants 4
- Bone pain in cancer: Consider bisphosphonates 1
Depression
- Pharmacological: Tricyclic antidepressants, selective serotonin reuptake inhibitors 1
- Non-pharmacological: Psychosocial interventions 1
- For anorexia/depression: Consider mirtazapine 4
Delirium
- First reduce/eliminate delirium-inducing medications (steroids, anticholinergics)
- Moderate delirium: Oral haloperidol, risperidone, olanzapine, or quetiapine 1
- Severe delirium/agitation: Haloperidol, olanzapine, or chlorpromazine 1
- Refractory agitation: Add lorazepam to neuroleptics 1
Constipation
- Preventive: Increase fluids, dietary fiber (if appropriate)
- Treatment: Laxatives, stool softeners, methylnaltrexone (for opioid-induced constipation) 1
Nausea/Vomiting
- Metoclopramide (caution with QT prolongation)
- 5-HT3 antagonists (setrons)
- Promethazine, prochlorperazine 1, 4
Special Considerations for End-of-Life Care (Days to Hours)
Medication Management
- Route of administration: Transition from oral to subcutaneous route (94% of patients near death) 5
- Discontinue non-essential medications 4
- Increase doses of symptom-control medications as needed 1
- Consider opioid rotation if delirium is believed to be caused by neurotoxicity 1, 4
Nutrition and Hydration
- Focus on comfort rather than nutritional goals
- Educate family that absence of hunger/thirst is normal in dying patients 4
Family Support
- Provide emotional and spiritual support
- Educate about the dying process
- Address caregiver burden and grief 1
Common Pitfalls to Avoid
- Delaying palliative care integration until the final days of life rather than introducing it early in disease trajectory
- Focusing solely on pharmacological interventions without implementing non-pharmacological strategies
- Avoiding opioids due to addiction concerns when they are essential for symptom control 4
- Continuing medications that no longer benefit the patient or may cause harm
- Neglecting psychosocial and spiritual needs of both patient and family
- Failing to complete advance care planning early in the disease course 1
By implementing both non-pharmacological and pharmacological approaches based on the patient's specific symptoms and estimated life expectancy, palliative care can significantly improve quality of life and provide comfort during the end-of-life journey.